“Evaluation of serum Cystatin C as a predictor of eGFR in type 2 diabetic patients with nephropathy” (2025) Journal of Shalamar Medical & Dental College - JSHMDC, 6(1), pp. 03–08. doi:10.53685/jshmdc.v6i1.294.